4baseCare and Innovate Life Sciences Partner to Transform Cancer Genomics in the Middle East

4baseCare partners with Innovate Life Sciences to advance precision oncology in the Middle East with cutting-edge genomics solutions. Announced at Dubai Science Park, this partnership focuses on personalized cancer treatments, emphasizing the importance of collaboration to manage cancer's rising economic burden and improve healthcare access.

In a breakthrough collaboration, 4baseCare, known for its precision oncology solutions, has teamed up with Innovate Life Sciences to pioneer advances in cancer care through genomics at Dubai Science Park. The partnership, announced on October 17, 2024, witnesses a strategic technology transfer aimed at personalized cancer treatment.

The event was graced by Marwan Abdulaziz Janahi, VP of Dubai Science Park, and Iqbal Khan, CEO of Fajr Capital, highlighting the partnership’s regional importance. With cancer rates escalating in Asia and the Middle East, this initiative promises significant progress in cancer genomics, focusing on personalized care.

Innovate Life Sciences will leverage 4baseCare's groundbreaking genomic testing tools to offer comprehensive genetic assessments, facilitating more precise and effective oncology treatments. This collaboration is set to address the pressing economic and healthcare challenges faced in the Middle East, promising a future where treatment is tailored to the genetic needs of each patient.

(With inputs from agencies.)